Agios Pharmaceuticals Chief Medical Officer Sarah Gheuens reports sale of $296,469.54 in common shares
AGIO•Chief Medical Officer Sarah Gheuens sold 7,866 Agios Pharmaceuticals common shares on Oct. 26, 2026, at a weighted-average price of $37.69, and exercised options to acquire 7,866 shares at $25.01 each.
1. Share transactions
Gheuens sold 7,866 common shares on Oct. 26, 2026, at a weighted-average price of $37.69 per share. She also exercised stock options to acquire 7,866 common shares at $25.01 per share. After the transactions, she directly owned 54,645 common shares and 16,275 stock options.
